Abstract Purpose of Review The goal of this paper is to review the latest findings in
understanding the genetics of diabetic retinopathy. We highlight recent literature using a …

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes
mellitus (DM). DR is complex and the term encompasses several clinical subtypes of …

Intraocular anti-vascular endothelial growth factor (VEGF) therapies are the front-line
treatment for diabetic macular edema (DME); however, treatment response varies widely …

Prevalence of diabetes is rising worldwide. In the course of the last 20 years, blindness and
low vision due to diabetic eye complications have increased in large regions in Eastern …

The present study aimed to investigate the mechanisms of anti‑VEGF treatment prior to eye
surgery to reduce intraoperative bleeding. A total of 30 patients with proliferative …

Diabetic macular edema (DME), a complication of diabetes mellitus, is a leading cause of
adult-onset blindness worldwide. Recently, intravitreal anti-VEGF injection has been used …

Introduction: Diabetic retinopathy (DR) is one of the major vision-threatening causes
worldwide. Searching for an individualized therapeutic strategy to prevent its progress is …

Diabetic macular edema (DME), the most common cause of vision loss in people with
diabetes, is a complex disease affecting the central part of the retina. The exact …

摘要背景: 理中汤是临床治疗糖尿病肾病的常用方, 但理中汤对糖尿病肾病防治作用的机制尚不
明确. 目的: 通过观察理中汤对2 型糖尿病大鼠肾功能, 肾组织形态及肾皮质血管内皮生长因子A …

Дисертація присвячена вирішенню актуального завдання сучасної офтальмології–
оптимізації сучасних підходів лікування вологої форми вікової макулярної дегенерації на …